Clinical Trial Update: AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 trial of AMG-479 in patients with advanced solid tumors and Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Prostate Cancer
• Sarcoma
• Small Intestine Cancer

Drugs mentioned

• AMG 479

Snippet

Sponsor: Amgen | Conditions: Lymphoma, Prostate Cancer | Phase 1 | Status: COMPLETED